BE547327A - - Google Patents
Info
- Publication number
- BE547327A BE547327A BE547327DA BE547327A BE 547327 A BE547327 A BE 547327A BE 547327D A BE547327D A BE 547327DA BE 547327 A BE547327 A BE 547327A
- Authority
- BE
- Belgium
- Prior art keywords
- insulin
- zinc
- solution
- hydroxyethoxy
- piperazine
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 16
- 102000004877 Insulin Human genes 0.000 claims description 8
- 108090001061 Insulin Proteins 0.000 claims description 8
- 229940125396 insulin Drugs 0.000 claims description 8
- LEMUFSYUPGXXCM-JNEQYSBXSA-N caninsulin Chemical compound [Zn].C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3N=CN=C3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1C=NC=N1 LEMUFSYUPGXXCM-JNEQYSBXSA-N 0.000 claims description 6
- XDPJQAWSYBMPOJ-UHFFFAOYSA-N 2-[2-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]ethoxy]ethanol Chemical compound OCCOCCN1CCN(CCOCCO)CC1 XDPJQAWSYBMPOJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000007900 aqueous suspension Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000003929 acidic solution Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 4
- 239000011701 zinc Substances 0.000 claims 4
- 229910052725 zinc Inorganic materials 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 claims 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 claims 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 239000012153 distilled water Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229940070805 p-chloro-m-cresol Drugs 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
- 239000011667 zinc carbonate Substances 0.000 claims 1
- 229910000010 zinc carbonate Inorganic materials 0.000 claims 1
- 235000004416 zinc carbonate Nutrition 0.000 claims 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE547327A true BE547327A (OSRAM) |
Family
ID=174333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE547327D BE547327A (OSRAM) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE547327A (OSRAM) |
-
0
- BE BE547327D patent/BE547327A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH513080A (fr) | Utilisation du monohydrate d'a-alumine pour préparer une dispersion aqueuse stable | |
| FR2665635A1 (fr) | Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation. | |
| CH647757A5 (fr) | Derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee. | |
| BE547327A (OSRAM) | ||
| RU2366459C1 (ru) | Способ профилактики кадмиевой нефропатии у экспериментальных животных при хроническом отравлении | |
| Neuhaus et al. | Biochemical studies on urokon (sodium 2, 4, 6-triiodo-3-acetylaminobenzoate), a new pyelographic medium | |
| FR2678832A1 (fr) | Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation. | |
| EP0069674A1 (fr) | Médicaments contenant une N-acyl-L-aspartyl-taurine | |
| CH368151A (fr) | Procédé de fabrication d'agents antidiabétiques | |
| FR2624736A1 (fr) | Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole | |
| EP0230199B1 (fr) | Nouveaux sels ferriques complexes de l'acide alpha, alpha'-(1,2-éthanodihylodiimine)-bis[5-carboxy-2-hydroxybenzénoacétique], et leur procédé de préparation | |
| EP0116182B2 (fr) | Procédé de préparation d'acide p-butoxyphénylacéthydroxamique à l'état finement divisé | |
| Hashimoto et al. | Acute and subchronic toxicity of a new fluorine pesticide, N-methyl-N-(1-naphthyl) fluoroacetamide | |
| BE495962A (OSRAM) | ||
| BE431123A (OSRAM) | ||
| JP2007332039A (ja) | 赤潮の除藻剤および赤潮の除藻方法 | |
| CH326787A (fr) | Procédé de fabrication de préparations injectables d'insuline à effet prolongé | |
| BE561072A (OSRAM) | ||
| JP2834568B2 (ja) | 魚毒性緩和剤 | |
| CH395971A (fr) | Procédé de préparation d'un nouvel ester de l'acide bêta cycloalkyl propionique | |
| BE543617A (OSRAM) | ||
| DE2429561B2 (de) | Verfahren zur herstellung von in 5-stellung substituierten 2-aminophenolen und bestimmte dieser aminophenole als solche | |
| MC437A1 (fr) | Ma late d'hydroxocobalamine et procédé de préparation | |
| BE705317A (OSRAM) | ||
| BE448285A (OSRAM) |